Fox Chase Cancer Center - Philadelphia
Philadelphia, Pennsylvania, 19111-2497, United States
NCT Number: NCT00459030
RATIONALE: Finding out which communication method affects a participant's decision to undergo colorectal cancer screening may help increase the number of participants who undergo screening. It is not yet known which communication method is more effective in increasing how often participants undergo colorectal cancer screening.
PURPOSE: This randomized clinical trial is studying traditional print communication methods to see how well they work compared with simple electronic communication methods or usual care in increasing how often older women undergo colorectal cancer screening.
Looking for future studies?
Notify Me50 year and older
Female
Interventional
Not applicable
Philadelphia, Pennsylvania, 19111-2497, United States
OBJECTIVES:
OUTLINE: This is a randomized study. Participants are randomized to 1 of 3 screening arms.
PROJECTED ACCRUAL: A total of 5,000 participants will be accrued for this study.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
DISEASE CHARACTERISTICS:
PATIENT CHARACTERISTICS:
PRIOR CONCURRENT THERAPY:
additional cancer screening information via password protected internet site
Time frame: End of study
Time frame: End of Study
Time frame: End of study
Fox Chase Cancer Center
Other
Two Delivery Channels to Improve CRC Screening
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07725692
Anastomotic Leak, Colon Cancer
Alexandria, Please Select, Egypt
View Trial DetailsNCT00102011
Colonic Diseases, Colonic Neoplasms
Shreveport, Louisiana, United States
View Trial DetailsNCT00556413
Colonic Diseases, Colonic Neoplasms
Montpellier, France
View Trial DetailsNCT06426927
Colon Adenocarcinoma, Colon Cancer
Chapel Hill, North Carolina, United States
View Trial Details